JPRN-UMIN000041321
Recruiting
Phase 4
emborexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study - Lemborexant for insomnia in patients with psychiatric disorder
Fujita Health University School of Medicine0 sites100 target enrollmentAugust 5, 2020
ConditionsInsomnia
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Insomnia
- Sponsor
- Fujita Health University School of Medicine
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The following exclusion criteria will be applied: taking any sleeping pills other than ramelteon, zolpidem, zopiclone, or eszopiclone at baseline; contraindication to suvorexant; patients with coma; addiction to psychostimulants or alcohol; pregnancy or breastfeeding; neurological or systemic diseases; and anyone considered inappropriate to participate by the attending physician. We will not include any patient who received benzodiazepines before the study because sleeping pills other than the Z drugs (zolpidem, zopiclone, or eszopiclone) or ramelteon.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Suvorexant for the treatment of insomnia in patients with psychiatric disorderspsychiatric disordersJPRN-UMIN000024941Fujita Health University School of Medicine50
Completed
Not Applicable
Efficacy and safety of lemborexant in insomnia patients with nocturia.JPRN-UMIN000044383Kyowakai Medical Corporation Kyoritsu Hospital30
Recruiting
Phase 1
Daridorexant to treat insomnia in patients with mild cognitive impairment and mild to moderate Alzheimer disease.Insomnia DisorderSLEEPAlzheimer DiseaseMedDRA version: 20.0Level: LLTClassification code: 10078083Term: Insomnia disorder Class: 10037175Therapeutic area: Diseases [C] - Nervous System Diseases [C10]CTIS2023-503301-10-00niversity Hospital Of Montpellier62
Not yet recruiting
Not Applicable
se of Lemborexant for Insomnia in Our Clinic: A Retrospective StudyJPRN-UMIN000054075Wellness General Clinic1,000
Completed
Not Applicable
Effects of Lemborexant on insomnia in patients with schizophrenia : A randomized controlled studyInsomnia in patients with schizophreniaJPRN-UMIN000049310Department of Psychiatry, Kurita Hospital, 695 Kurita Nagano-City Nagano, Japan, 380-0921